Dr. Richard Moulange

speaker

1,784 appearances 1 recordings 1 series first heard Mar 2026 last heard 31 Mar

Dr. Richard Moulange’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 1 in all, peaking in Mar 2026 with 1.

Appearances

newest first · ▶ plays the moment

80,000 Hours Podcast · #241 – Richard Moulange on how now AI codes viable genomes from scratch and outperforms virologists at lab work — what could go wrong? · 31 Mar 2026 podcast

what I call defenders, people who are building the next generation vaccines, people who are building the next generation biosurveillance systems to be using those models precisely for defensive purposes.

I don't think we should be hobbling those people working hardest to reduce biological risks in the world by not, in fact,

giving them the best tools, including tools that will allow them to discuss anthrax sometimes if they need to, if it's a legitimate part of their work.

But we have to build the infrastructure, and I think this is both on companies and governments, build the infrastructure to be able to share those capabilities safely and only with the right people.

And when you do that, eventually, we might need to be in a world where, yes, you have, I don't know, chat GPT-8 or something, but maybe you also have chat GPT-8 bio.

And there is a separate model that really knows a lot more about biology that is allowed only for people who build defensive biological capabilities.

I think the companies and governments are not doing enough to empower national security actors working on critical defensive technologies.

I think there are a number of existing things.

We should not be building this from scratch.

And it's not just on the companies, and nor is it just on government.

It needs to be a public-private partnership.

So a few things that we can work with.

One is there are trusted tester schemes.

Google DeepMind doesn't let everyone under the sun have access to Alpha Proteo, their most powerful biodesign capability.

So that is precedent.

That's proof of concept that sometimes it is okay to restrict things a bit, but in return for empowering the right people.

But having an email address that you email and then maybe they do some like KYC, know your customer checks, I don't know, doesn't seem sufficient.

Yes, we should be piggybacking on national security clearance.

So in the UK, the government has different levels of clearance.

It's not obvious to me that you would only need sort of the highest level, so-called developed vetting for access to top secret information.

Showing 821–840 of 1,784 · page 42 of 90